U.S. House of Representatives

Foreign Affairs Committee

Genetics and other Human Modification Technologies: Sensible International Regulation or a New Kind of Arms Race?

  1. Home
  2. All Hearings
  3. Hearings
  4. Genetics and other Human Modification Technologies: Sensible International Regulation or a New Kind of Arms Race?

Congress: 110th
Location: Room 2200 of the Rayburn House Office Building

Paul R. Billings M.D., Ph.D. President and Chief Executive Officer Cellpoint Diagnostics, Inc. Jamie F. Metzl, Ph.D Executive Vice President Asia Society Nigel M. de S. Cameron, Ph.D. President and Co-founder Institute on Biotechnology and the Human Future Richard Hayes, Ph.D. Executive Director Center for Genetics and Society

Transcript [PDF] (Not available)

Committee Hearings

View All Committee Activity